Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0000899243-20-006635

Options or other derivatives

  • Co-CEO and Director acquired 1,266,490 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patel Chintu Co-CEO and Director 2020-02-27 Grant or award · Performance-Based Restricted Stock Units +1,266,490 1,266,490 D
Loading xslF345X03/doc4.xml…